Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 months ago

Possible Interaction: Fatty Acids, Omega-3 and Homocysteine

supplement:

Homocysteine

Research Papers that Mention the Interaction

Whether n-3 polyunsaturated fatty acids increase LDL susceptibility to oxidation or influence homocysteine (Hcy) metabolism has long been a subject of controversy.
The Journal of laboratory and clinical medicine  •  2003  |  View Paper
CONCLUSIONS Our study showed a significant reduction regulated by omega-3 supplementation in serum homocysteine level which is a cardiovascular risk factor among hemodialysis patients.
Iranian journal of kidney diseases  •  2013  |  View Paper
They showed the omega-3 reduced the homocysteine level in 8 weeks.
This study faced us with 3 questions: Does the omega-3 have a direct effect on decreasing the homocysteine level in hemodialysis patients?
Iranian journal of kidney diseases  •  2013  |  View Paper
BackgroundPrevious studies showed that plasma n-3 polyunsaturated fatty acid (PUFA) was negatively associated with plasma homocysteine (Hcy).ObjectiveWe investigated the regulatory effect of n-3 PUFA on mRNA expression of the critical genes encoding the enzymes involved in Hcy metabolism.
Nutrition Journal  •  2012  |  View Paper
CONCLUSION The consumption of omega-3 fatty acid supplements (3g/day) for 2months decreases the levels of homocysteine in diabetic patients with no change in FBS, MDA and CRP levels.
Due to omega-3 fatty acid supplementation, homocysteine was changed significantly in both treatment and control groups up to -3.10mumol/L and 0.10mumol/L respectively, and HbA(1)c decreased by 0.75% in the treatment group and increased by 0.26% in the control group.
Nutrition, metabolism, and cardiovascular diseases : NMCD  •  2010  |  View Paper